FBXO32 and muscle atrophy: Targeting Atrogin1 and MuRF1 in knockout models or modulating these ubiquitin ligases through physical activity and exercise has been shown to have the ability to protect against and/or reverse muscle atrophy in patients suffering from sarcopenia [41].